Menu
No results found.
Weekly Share Price & Valuation Overview
Bastide Le Confort Médical SA
Bastide Le Confort Médical SA engages in the sale and rental of medical equipment for individuals and health professionals in France and internationally. The company provides medical materials, such as lift chairs, bathroom medical equipment, medical measuring devices, medical pillows, sitting posture aids, senior electrostimulation devices, heating products, comfort shoes, natural food supplement, first aid products, shopping carts, senior telephone, pedalboard for the elderly, pressotherapy devices, technical help, bed tables, medical rooms, sleep apnea devices, electric scooter for people with reduced mobility, wheelchair manual and electric, walker and rollators, and walking sicks; and wellness accessories comprising circulatory stimulators, revivals, relaxation, organic natural massage gel and essential oils, and pedicure and foot care products. It offers incontinence products, including absorbent briefs, compete adult change, anatomical protections, urinary protections, traversable straight protections, disposable pads, support briefs, mesh briefs, adult onesie, feminine protections, hygiene incontinence, and incontinence swimsuits. In addition, it offers rental and services for medical bed, wheelchair, air mattress, patient lift, and verticalizer; and professional equipment, such as consumable for healthcare prodessionals, hygiene and disinfection, care and dressings, diagnosis and self-check, medical equipment, and professional health packs products. Bastide Le Confort Médical SA was founded in 1977 and is headquartered in Caissargues, France.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Debt-to-equity >2 — elevated leverage may constrain flexibility.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- EUR 202.85M
- Enterprise Value Operating value: market cap + total debt − cash.
- EUR 595.95M
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- EUR 540.26M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- EUR 364.87M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- EUR 90.63M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- EUR 72.38
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 1.16
- Shares Outstanding
- 7.31M
- Float Shares
- 3.35M
- Implied Shares Outstanding
- 7.56M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
9.53%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
16.77%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
67.54%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
0.32%
- ROA Return on assets: net income ÷ total assets.
-
4.53%
- ROE Return on equity: net income ÷ shareholder equity.
-
10.46%
- Revenue Growth Year-over-year revenue growth.
-
4.00%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
4.58%
- Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
- 0.87
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 5.42
- Total Cash Cash and equivalents.
- EUR 31.30M
- Total Debt Short + long-term interest-bearing debt.
- EUR 420.68M
- Net Debt Total debt − cash (negative = net cash).
- EUR 389.37M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 4.64
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- EUR 112.14M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- EUR 17.46M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
20.76%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
3.23%
- Cash Conversion (OpCF/EBITDA)
- 1.24
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.